May 22, 2017 12:08 pm UTC| Business
NEW YORK, May 22, 2017 -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, announced today positive...
Equity Bancshares Promotes Julie Huber to New Strategic Leadership Role
May 22, 2017 12:08 pm UTC| Business
WICHITA, Kan., May 22, 2017 -- Equity Bancshares, Inc. (NASDAQ:EQBK), (“Equity”, “we”, “us”, “our”, or “the Company”), the Wichita-based holding company of Equity Bank, announced the promotion of Julie Huber, Executive...
May 22, 2017 12:08 pm UTC| Business
NEW YORK, May 22, 2017 -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, announced today positive...
May 22, 2017 12:08 pm UTC| Business
NEW YORK, May 22, 2017 -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, announced today positive...
May 22, 2017 12:09 pm UTC| Business
NEW YORK, May 22, 2017 -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, announced today positive...
Union Bankshares Corporation Announces Agreement to Acquire Xenith Bankshares, Inc.
May 22, 2017 12:06 pm UTC| Business
RICHMOND, Va., May 22, 2017 -- Union Bankshares Corporation (NASDAQ:UBSH) or (“Union”) and Xenith Bankshares, Inc. (NASDAQ:XBKS) or (“Xenith”) jointly announced today that they have entered into a definitive merger...
Union Bankshares Corporation Announces Agreement to Acquire Xenith Bankshares, Inc.
May 22, 2017 12:06 pm UTC| Business
RICHMOND, Va., May 22, 2017 -- Union Bankshares Corporation (NASDAQ:UBSH) or (“Union”) and Xenith Bankshares, Inc. (NASDAQ:XBKS) or (“Xenith”) jointly announced today that they have entered into a definitive merger...